≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other leukaemias of specified cell type

Endpoint Browser PheWeb

CD2_OTHER_LEUKAEMIA_SPECIFIED_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C94
  • Hospital discharge: ICD-9 — 207[0-8]
  • Hospital discharge: ICD-8 — 207[0-2]
  • Cause of death: ICD-10 — C94
  • Cause of death: ICD-9 — 207[0-8]
  • Cause of death: ICD-8 — 207[0-2]

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF8
Parent code in ICD-10
C81-C96
Name in latin
Aliae leuc(h)aemiae typo cellulari specificato

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 89 48 41
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 54.77 52.22 57.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
80
Matched controls
801
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
213.2
37.4
36
*
127
Kela drug reimbursment
Transplant complication
104.4
30.7
32
5
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
25.4
23
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
35.0
21.9
28
12
XW000
NOMESCO Finland
Bone marrow biopsy
39.8
21.8
27
10
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
19.6
18
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
20.9
19.2
29
21
L04AD01
ATC
ciclosporin; systemic
55.9
18.3
21
5
L04AA06
ATC
mycophenolic acid; systemic
55.9
18.3
21
5
ZX120
NOMESCO Finland
Intravenous
14.2
15.9
28
29
L04AA01
ATC
[U] ciclosporin; systemic
34.9
15.1
19
7
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
65.6
14.4
16
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
13.9
13
*
L03AA02
ATC
filgrastim; parenteral
167.2
13.9
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.9
13.2
28
41
WW500
NOMESCO Finland
Blood transfusion
20.3
12.9
19
12
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.0
12.9
54
205
H02AB02
ATC
dexamethasone; systemic
153.0
12.8
13
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
76.5
12.0
13
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
11.7
11
*
H02AB09
ATC
hydrocortisone; systemic
41.7
11.7
14
*
Z94.0
ICD-10 Finland
Kidney transplant status
41.7
11.7
14
*
R50.9
ICD-10 Finland
Fever, unspecified
8.3
11.5
27
46
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
10.3
11.4
23
30
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
51.0
11.3
13
*
R4110
NOMESCO Finland
Physiotherapy
5.7
10.9
38
110
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
+∞
10.6
10
*
Z3231
NOMESCO Finland
Registered nurse
5.1
10.4
42
142
Z3226
NOMESCO Finland
Physiotherapist
5.9
10.3
33
85
TK800
NOMESCO Finland
Hemodialysis
23.8
10.2
14
7
Z49.1
ICD-10 Finland
Extracorporeal dialysis
62.9
9.9
11
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
34.8
9.7
12
*
ZX108
NOMESCO Finland
Inhalation
112.8
9.6
10
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
9.6
9
*
C03CA01
ATC
furosemide; systemic
5.0
9.5
37
118
J01MA12
ATC
levofloxacin; systemic
6.1
9.4
28
65
H02AB04
ATC
methylprednisolone; systemic
6.0
9.1
27
62
A05AA02
ATC
ursodeoxycholic acid; oral
56.4
8.9
10
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.8
8.9
27
64
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
16.9
8.5
13
9
C94.4
ICD-10 Finland
Acute panmyelosis with myelofibrosis
+∞
8.5
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.5
8
*
ZZR00
NOMESCO Finland
Flap of skin
+∞
8.5
8
*
C94.2
ICD-10 Finland
Acute megakaryoblastic leukaemia
+∞
8.5
8
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
8.5
8
*
TAB00
NOMESCO Finland
Lumbar puncture
13.8
8.5
14
12
A11CC03
ATC
alfacalcidol; systemic
37.6
8.3
10
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
37.6
8.3
10
*
Z2221
NOMESCO Finland
Medical doctor
4.3
8.3
37
132
TGC00
NOMESCO Finland
Bronchial lavation
17.3
8.0
12
8
Z2446
NOMESCO Finland
Social worker
8.0
8.0
18
28
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
50.1
7.9
9
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
50.1
7.9
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.4
7.8
21
42
N18.8
ICD-10 Finland
Other chronic renal failure
28.2
7.8
10
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.0
7.6
17
26
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
87.9
7.6
8
*
J05AB01
ATC
aciclovir; systemic
4.6
7.5
29
88
JN4BD
NOMESCO Finland
Extensive body CT
10.3
7.4
14
16
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
7.4
7
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
7.4
7
*
C94.1
ICD-10 Finland
Chronic erythremia
+∞
7.4
7
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
11.7
7.4
13
13
A12AA04
ATC
calcium carbonate; oral
33.3
7.3
9
*
ZXD05
NOMESCO Finland
Urgent procedure
4.0
7.2
36
137
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.6
7.1
27
80
ZXE30
NOMESCO Finland
More than five and less than seven hours
10.8
7.1
13
14
B03XA02
ATC
darbepoetin alfa; parenteral
43.9
6.9
8
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
10.1
6.9
13
15
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
10.1
6.9
13
15
Z3229
NOMESCO Finland
Other healthcare associate professional
6.3
6.8
18
35
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.7
6.8
14
19
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.7
6.8
14
19
J01MA14
ATC
moxifloxacin; systemic
7.1
6.7
16
27
ZXE10
NOMESCO Finland
More than one and less than three hours
3.6
6.7
40
175
ZXA00
NOMESCO Finland
Right side
3.9
6.6
33
123
TPH04
NOMESCO Finland
Cathetrisation of vein
4.1
6.6
28
92
6BA02
NOMESCO Finland
NA
75.6
6.5
7
*
Z94.1
ICD-10 Finland
Heart transplant status
75.6
6.5
7
*
B03XA01
ATC
erythropoietin; parenteral
75.6
6.5
7
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
12.5
6.5
11
10
J05AB11
ATC
valaciclovir; oral
5.0
6.4
21
53
TPX10
NOMESCO Finland
Implantation of vascular injection port
20.0
6.4
9
5
ZX112
NOMESCO Finland
Subcutaneous
29.2
6.4
8
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
6.3
6
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
6.3
6
*
20700
ICD-8 Finland
Other and unspecified leukaemia, Leukaemia, acute
+∞
6.3
6
*
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
6.3
6
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
6.3
30
109
L01BB02
ATC
mercaptopurine; oral
16.6
6.1
9
6

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
25
24
14.10
23.79
2.1
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
28
9
44.40
23.22
13.9
1.8
iu/ml
338.2
—
—
12
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
42
88
8.14
21.62
22.0
5.2
mmol/l
1.1
1.1
0.16
42
82
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
15
15.83
20.08
1.5
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
24
11.85
19.04
1.5
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
20
21
11.99
17.69
12.5
5.3
mg/l
1.8
1.4
0.95
20
21
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
70
7.24
17.39
2.2
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
97
6.67
17.35
4.0
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
31
58
7.67
17.35
6.0
2.8
e9/l
71.3
66.6
0.33
22
44
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
37
9.01
17.14
3.5
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
40
101
6.38
16.53
11.3
2.4
mmol/l
0.8
0.8
0.90
40
94
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
13
14.79
16.48
6.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
11
16.20
16.32
5.5
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
70
6.90
16.29
2.3
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
14
13.71
15.76
5.4
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
34
77
6.53
15.65
8.9
2.7
%
1.9
1.6
1.29
34
70
(3018418) pH of Serum or Plasma
54
186
5.84
15.57
17.0
3.0
ph
7.4
7.4
—
8
25
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
9
28.12
15.02
1.6
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
49
163
5.46
14.52
12.4
4.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
18
10.62
13.31
2.3
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
68
321
5.74
12.54
25.9
5.7
mmol/l
1.2
1.2
0.37
62
285
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
73
5.69
12.53
2.4
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
12
12.52
12.25
2.4
3.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
12
12.52
12.25
3.2
3.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
17
9
22.93
12.14
1.6
1.0
u/ml
137.4
—
—
7
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
5
35.53
12.09
1.4
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
24
8.52
11.87
4.3
2.6
%
88.7
84.6
0.20
17
24
(3017181) Myelocytes/100 leukocytes in Blood
23
46
6.39
11.74
14.7
5.4
%
1.8
0.3
2.01
17
14
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
6
29.63
11.58
2.8
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
56
244
4.49
11.00
18.0
5.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
46
6.02
10.68
1.5
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
14
6
27.25
10.62
1.4
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
6
27.25
10.62
3.6
2.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
43
6.08
10.40
14.6
5.6
%
0.5
0.0
1.82
16
12
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
10
12.41
10.36
2.8
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
44
172
4.08
9.80
21.2
4.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
67
353
4.63
9.70
20.9
5.4
%
55.2
56.9
0.39
67
330
(3045142) Bone marrow Pathology biopsy report
13
6
24.98
9.67
1.7
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
30
93
4.36
9.10
5.5
2.2
g/l
2.1
2.4
1.19
30
87
(3002179) Metamyelocytes/100 leukocytes in Blood
18
41
5.25
7.84
13.1
5.9
%
1.3
0.0
—
9
10
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
11
6
20.62
7.82
6.6
5.0
mg/l
13.2
11.8
—
11
6
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
30
106
3.76
7.44
2.5
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
7
0
+∞
7.39
1.0
0.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
29
101
3.78
7.33
5.8
2.2
umol/l
12.1
14.8
1.48
29
93
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
39
5.15
7.33
2.3
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
22
64
4.24
7.11
12.2
8.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
25
80
3.96
7.11
2.5
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
34
135
3.46
7.02
2.4
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
49
243
3.26
7.02
7.9
3.3
—
—
—
0
0
(44806118)
10
7
15.86
6.57
3.1
1.4
—
—
—
0
0
(44790047)
10
7
15.86
6.57
3.1
1.4
—
—
—
0
0
(44790049)
10
7
15.86
6.57
3.1
1.4
—
—
—
0
0
(44790048)
10
7
15.86
6.57
3.1
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
37
162
3.20
6.44
6.6
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
59
338
3.21
6.41
25.3
3.8
umol/l
11.5
12.4
0.27
59
315
(3025159) Blasts/100 leukocytes in Blood
17
44
4.54
6.33
13.4
5.4
%
0.4
0.0
0.98
11
11
(3024932) HLA-DR beta [Type]
6
0
+∞
6.32
1.3
0.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
43
208
3.07
6.27
8.4
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
54
300
3.03
6.09
14.0
3.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
41
196
3.02
6.06
6.0
1.8
mmol/l
2.3
2.4
1.10
41
158
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
6
16.46
6.04
2.9
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
34
147
3.12
5.98
4.6
2.3
e6/l
3.6
5.8
0.97
34
124
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
9
12.32
5.96
2.3
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
9
12.32
5.96
2.8
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
55
313
2.98
5.87
29.1
7.5
e9/l
0.0
0.0
1.12
45
235
(3042936) Bacteria identified in Isolate by Culture
26
97
3.37
5.81
3.6
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
41
201
2.93
5.73
5.8
2.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
7
14.10
5.71
6.7
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
7
14.10
5.71
6.7
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
7
14.10
5.71
6.7
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
7
14.10
5.71
6.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
42
209
2.91
5.71
5.9
3.0
e6/l
0.2
0.5
1.22
37
149
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
18
6.13
5.45
6.4
4.3
mmol/l
23.4
22.5
—
10
13
(3032080) INR in Blood by Coagulation assay
48
262
2.81
5.41
26.9
6.7
inr
1.2
1.2
0.07
14
63
(3002582) Erythrocytes [#/volume] in Urine
43
223
2.80
5.33
6.8
3.0
e6/l
38.8
61.5
0.27
38
163
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
0
+∞
5.25
3.0
0.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
0
+∞
5.25
1.2
0.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
0
+∞
5.25
2.2
0.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
0
+∞
5.25
1.6
0.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
0
+∞
5.25
2.2
0.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
17
51
3.88
5.19
8.4
4.1
mmol/l
1.3
2.2
0.44
12
30
(3026008) Bacteria identified in Urine by Culture
41
210
2.77
5.17
3.8
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
31
137
2.94
5.15
4.5
2.6
e6/l
0.9
1.1
0.12
21
72
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
10
9.85
4.91
6.1
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
49
3.76
4.73
6.2
1.7
ml/min/173m2
51.4
67.9
—
5
21
(3002173) Hemoglobin [Mass/volume] in Arterial blood
16
49
3.76
4.73
9.1
9.2
g/l
108.8
122.1
2.01
16
49
(40760888) Immunoglobulin light chains.free panel - Serum
7
5
15.01
4.65
9.1
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
8
10.83
4.62
19.6
4.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
56
3.52
4.52
5.3
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
9
9.62
4.37
2.9
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
30
141
2.70
4.36
16.3
5.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
12
32
4.18
4.24
10.3
10.9
%
0.7
0.6
0.28
12
32
(40768804) Tissue Pathology biopsy report
40
219
2.50
4.24
2.9
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
28
129
2.71
4.21
5.6
2.8
e6/l
1.5
2.4
0.32
17
64
(3025941) Bacteria identified in Stool by Culture
11
28
4.34
4.11
2.4
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
12
33
4.05
4.08
10.3
10.7
%
1.4
1.7
0.28
12
33
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
24
4.57
4.00
4.4
2.8
u/ml
0.3
0.4
—
5
15
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
8
9.37
3.84
2.7
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
8
9.37
3.84
1.1
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
31
157
2.50
3.81
3.8
1.3
g/l
2.1
2.5
0.43
24
78
(3018095) Leukocytes [#/volume] in Urine
44
262
2.34
3.77
8.4
3.5
e6/l
67.5
167.6
0.98
38
174
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
35
3.81
3.77
2.4
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
46
3.42
3.72
5.6
3.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
72
536
2.80
3.70
26.9
5.1
u/l
92.3
84.5
0.49
72
491
(3004588) Protein electrophoresis panel - Serum or Plasma
13
44
3.29
3.29
5.9
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
8
7.94
3.10
4.3
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
8
7.94
3.10
2.5
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
5
10.48
3.01
4.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
5
10.48
3.01
4.2
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
5
10.48
3.01
1.2
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
5
10.48
3.01
4.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
5
10.48
3.01
4.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
5
10.48
3.01
4.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
5
10.48
3.01
4.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
5
10.48
3.01
2.6
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
17
5.06
2.99
1.3
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
17
5.06
2.99
1.3
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
30
168
2.19
2.84
8.6
4.0
estimate
0.0
0.0
—
7
60
(3044290) Cell count panel - Cerebral spinal fluid
7
14
5.33
2.78
8.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
14
5.33
2.78
4.6
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
6
8.73
2.78
1.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
10
6.34
2.74
4.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
32
187
2.11
2.70
2.0
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
51
355
2.02
2.66
6.8
3.4
estimate
0.0
0.0
—
9
55
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
43
283
2.00
2.62
1.7
1.9
pmol/l
86.2
93.5
0.46
26
140
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
11
5.76
2.58
1.7
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
45
302
1.99
2.58
6.9
2.4
ug/l
327.9
102.2
3.65
45
277
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
21
4.08
2.53
1.0
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
50
351
1.97
2.50
8.6
4.7
estimate
0.0
0.0
—
8
58
(3022313) Gas panel - Capillary blood
11
41
2.92
2.38
8.4
3.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
89
2.28
2.25
3.0
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
9
5.81
2.24
1.2
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
29
174
1.99
2.23
5.5
3.1
—
—
—
0
0
(3020891) Body temperature
7
19
3.90
2.20
14.4
7.1
—
—
—
0
0
(3015736) pH of Urine
42
287
1.88
2.20
4.9
3.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
14
4.51
2.19
6.2
2.9
e9/l
3.5
5.3
—
6
14
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
14
4.51
2.19
7.5
4.1
%
54.8
60.6
—
6
14
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
14
4.51
2.19
1.7
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
31
3.11
2.14
5.9
9.5
—
—
—
0
0
(3002256) Pathology report gross observation
14
63
2.45
2.14
1.8
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
20
3.71
2.10
8.4
1.1
e6/l
55.0
4.2
—
7
15
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
20
3.71
2.10
8.4
1.2
e6/l
64.3
470.9
—
7
15
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
10
5.22
2.10
1.4
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
48
350
1.81
1.98
7.1
3.4
estimate
0.0
0.0
—
9
60
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
22
3.36
1.92
10.4
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
22
3.36
1.92
3.7
3.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
40
2.69
1.91
21.9
2.2
mmol/l
1.2
1.2
—
10
35
(3020682) Albumin/Creatinine [Ratio] in Urine
34
226
1.82
1.89
6.1
4.0
mg/mmol
28.4
6.9
1.01
27
138
(3019060) Gas panel - Arterial blood
9
35
2.74
1.86
5.9
5.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
37
257
1.75
1.75
7.6
3.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
32
214
1.77
1.72
5.7
3.3
mg/l
1628.6
353.9
0.37
27
133
(3003181) Sodium [Moles/volume] in Urine
5
15
3.47
1.54
1.8
2.9
mmol/l
82.2
53.7
—
5
15
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
21
2.99
1.53
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
22
2.85
1.46
4.3
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
59
481
1.67
1.45
6.1
3.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
5
18
2.88
1.30
3.2
1.4
nmol/l
59.4
36.9
—
5
18
(3034770) Mitochondria Ab [Titer] in Serum
5
20
2.59
1.16
1.2
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
21
2.46
1.10
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
61
1.92
1.04
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
29
0.00
0.99
0.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
52
1.81
0.95
8.0
2.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
29
2.14
0.91
2.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
29
2.14
0.91
2.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
29
2.14
0.91
2.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
16
231
0.63
0.89
2.2
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
58
502
1.45
0.86
8.7
4.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
58
1.82
0.83
11.2
6.0
mmol/l
24.6
25.2
—
10
58
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
26
0.00
0.80
0.0
1.2
—
2.0
—
0
15
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
27
0.00
0.79
0.0
1.4
—
1.9
—
0
14
(3041096) Erythrocytes [Presence] in Urine by Automated
24
180
1.46
0.76
7.7
3.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
5
24
2.15
0.76
3.2
4.9
%
1.3
1.7
—
5
24
(3037121) Protein [Mass/volume] in Urine
5
25
2.06
0.74
3.4
3.8
g/l
0.5
0.1
—
5
10
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
25
2.06
0.74
1.2
2.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
28
1.83
0.67
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
53
469
1.32
0.58
3.0
3.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
9
59
1.58
0.57
1.8
3.5
ng/l
296.9
310.1
—
9
52
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
74
1.56
0.56
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
10
66
1.58
0.55
2.0
1.4
—
—
—
0
0
(3019225) pH of Specimen
9
63
1.48
0.54
11.2
3.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
67
618
1.34
0.52
60.0
14.0
%
14.5
13.6
3.36
67
608
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
46
1.57
0.49
1.1
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
65
696
0.75
0.49
5.9
4.2
mmol/l
5.9
6.0
0.60
59
637
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
31
261
1.29
0.47
7.7
3.3
ng/l
37.2
51.7
0.38
26
173
(40761536) Microorganisms panel - Urine sediment
7
49
1.46
0.47
4.3
3.8
—
—
—
0
0
(3013512) EKG study
14
180
0.74
0.42
6.4
3.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
73
765
0.75
0.40
40.9
10.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
77
733
1.37
0.40
58.5
11.4
mg/l
27.2
22.5
0.90
72
537
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
81
1.41
0.38
16.8
6.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
75
0.65
0.37
1.2
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
44
1.39
0.35
2.3
1.3
—
—
—
0
0
(4010399)
6
46
1.33
0.34
2.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
95
0.71
0.33
1.7
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
17
141
1.25
0.29
1.5
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
72
1.28
0.27
2.9
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
40
1.26
0.23
1.8
1.8
—
—
—
0
0
(4027681)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.6
—
0
5
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
1.5
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
51
480
1.15
0.21
6.8
3.0
u/l
53.9
47.5
0.32
51
449
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
85
0.81
0.15
1.6
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
10
115
0.85
0.11
1.1
1.3
u/ml
5.2
8.8
—
5
36
(3009542) Hematocrit [Volume Fraction] of Blood
70
685
1.10
0.09
45.2
13.0
%
34.2
40.4
3.82
55
517
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
11
123
0.88
0.08
1.0
1.3
iu/ml
17.5
35.5
—
5
43
(40768797) Stomach Pathology biopsy report
9
88
1.03
0.07
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
65
641
1.05
0.03
42.9
10.6
ml/min/173m2
70.4
81.0
1.98
58
494
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
76
768
0.93
0.03
34.4
8.5
u/l
27.3
26.4
0.17
76
746
(3020564) Creatinine [Moles/volume] in Serum or Plasma
76
767
0.94
0.02
56.8
12.7
umol/l
111.4
76.0
1.79
76
767
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
68
674
1.04
0.00
4.9
4.5
mu/l
2.0
1.9
0.43
63
621
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
102
0.98
0.00
1.8
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
1.3
—
13.3
—
0
7
(21494755) Public health laboratory ask at order entry panel
6
60
1.00
0.00
1.2
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
5
58
0.85
0.00
2.4
2.5
—
6.7
—
0
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
17
170
1.00
0.00
2.6
3.2
%
34.5
24.1
—
8
78
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
24.4
—
0
5
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
54.6
—
0
5
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
67
0.89
0.00
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
2.2
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_OTHER_LEUKAEMIA_SPECIFIED_EXALLC – Other leukaemias of specified cell type

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).